Neudle.com: L dopa

Neurology Specific Literature Search

Differential
(Click to cross reference)

abdominal protrusion

advances in neurology

adverse drug reaction

affective disorders

akinesia of eyelid function

alcohol, neurologic complications with

alien hand syndrome

alpha methyldopa hydrazine

alpha methyltyrosine

alpha-synuclein

alternative medicine

Alzheimer's disease

amphetamines, dyskinesia associated with

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, etiology of

anemia, iron deficiency

anesthesia, general

anticholinergic drugs

anticholinergic drugs, side effects of

anticonvulsants

aphasia, progressive, primary

apraxia of eyelid opening

apraxia, constructional

aqueduct of Sylvius, stenosis

arm swing, reduced

arrhythmia, cardiac

arterial dissection, aorta, cerebral symptoms with

aspartate aminotransferase

attention deficit disorder with hyperactivity

auditory and vestibular pathways

autonomic cardiovascular reflexes

autonomic dysfunction

autonomic dysfunction, evaluation of

autonomic nervous system

ballismus, bilateral

basal ganglia, infarction

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

beta adrenergic blocker

Binswanger disease

biopterin deficiency

bladder dysfunction

blinking, reduced

botulinum toxin

brain implant, polymeric

brain transplantation

brainstem, lesion of

Brueghel's syndrome

burning paresthesia

burst suppression pattern, electroencephalogram

CAT scan, abnormal

CAT scan, emission

CAT scan, emission, abnormal

catechol-o-methyltransferase inhibitor

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortical atrophy

cerebral infarction, subcortical

cerebral ischemia

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrovascular accident

cerebrovascular disease

chromosomal abnormality

cigarette smoking

Clinical Pathologic Conference(C.P.C.)

clinical trials

cogwheel rigidty

compulsive singing

contractures, joint

contrast sensitivity

controversies in neurology

Coombs test, positive

cortical-basal ganglionic degeneration

cost effectiveness

crying, pathologic

cyst, arachnoid, infant

dantrolene sodium

degenerative diseases of CNS

delay in diagnosis

dementia, subcortical

dementia, treatment of

developmental milestones, loss of

dexterity, impaired

diabetes mellitus

diagnostic criteria

differential diagnosis

disability rating scale, neurological

disability, neurological

diurnal variation

dopa responsive dystonia

dopamine agonist

dopamine antagonist

dopamine receptor

dopamine receptor, D2

dopaminergic dysfunction

drug induced neurologic disorders

drug interactions

drug withdrawal

dyskinesia, buccal lingual facial

dyskinesia, drug induced

dyskinesia, facial

dystonia musculorum deformens

dystonia, children

dystonia, etiology of

dystonia, evaluation of

dystonia, focal

dystonia, painful

dystonia, prevalence of

dystonia, symptomatic

dystonia, treatment of

electroconvulsive therapy

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, periodic complexes

electroencephalogram, triphasic delta waves

electron microscopy

encephalitis, viral

encephalopathy, progressive

enzyme inhibition

epidemiology of neurology

evidence-based research

extrapyramidal movement disorder, progressive

eye movement, disorders of

failed medical management

fine motor function, impaired

fludrocortisone

frontal behavioral spatial syndrome

gait, festinating

gamma amino butyric acid

gastrointestinal bleeding

gaze palsy, supranuclear

gaze palsy, vertical

genetic counselling

genetic neurologic disorders

genetic screening

genetic testing

Gilles de la Tourette syndrome

globus pallidus, stimulation

glomus jugulare tumor

hallucination, visual

head injury, brain stem lesion after

head injury, prognosis in

head injury, severe

hepatic encephalopathy

hepatic encephalopathy, treatment of

hepatolenticular degeneration(Wilson's disease)

heralding manifestation

homovanillic acid

hummingbird sign

Huntington's chorea

Huntington's chorea, presymptomatic detection of

hydroxyindole acetic acid 5(5HIAA)

hydroxytryptophan L-5(L-5 HTP)

hypometric saccades

hypotension, systemic

iatrogenic neurologic disorders

ideomotor apraxia

imbalance, postural

inclusion bodies

inclusion bodies, eosinophilic cytoplasmic

intellectual deficit

intranasal medication

Isaacs syndrome

jaw jerk, abnormal

judgement, impaired

kinesia paradoxica

laughing, pathologic

L-dopa methyl ester

L-dopa, absorption

L-dopa, controlled release

L-dopa, delayed treatment in Parkinsonism

L-dopa, drug interactions with and side effects of

L-dopa, enteral infusion, continuous

L-dopa, intravenous

L-dopa, plasma concentration

L-dopa, potentiators of

leg spasms, painful

Lesch-Nyhan syndrome

leukoencephalopathy

Lewy body disease, diffuse

livedo reticularis

liver function enzymes

locus ceruleus, lesion of

manganese intoxication

manic-depressive

marche a petits pas

melanoma, malignant

memory, defect of recent

memory, impairment of

mental status, abnormal

microangiopathy, brain

midbrain, atrophy

midbrain, lesion of

migraine, treatment of

Mini Mental Status Examination

mitochondrial disease

molecular genetics

monoamine oxidase inhibitors

monoamines, brain

movement disorder

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, treatment of

MRI, functional

multiple sclerosis

multiple sclerosis, diet in

multiple sclerosis, treatment of

multiple system atrophy

muscle atrophy, static

muscle stiffness

muscle weakness

myasthenic syndrome

myasthenic syndrome, treatment of

myoclonic jerks

myoclonus, sleep

nausea and vomiting

neoplasm, hormone producing

neoplasm, hormone producing, ectopic

neuroendocrinology

neuroleptic malignant syndrome

neuroleptic sensitivity

neuroleptic, atypical

neurologic complications of, surgery

neurologic disease, diagnoses of

neurologic disease, tempo

neurologic signs

neurologic symptoms

neuronal degeneration

neuroophthalmology

neuropathology, brain

neuropathy, peripheral

neuroprotective agents

neurotransmitter

nigrostriatal pathway

obsessive-compulsive disorder

occupational neurologic disorders

ocular myopathy

ocular myopathy, differential diagnosis

old age, neurology of

ophthalmoplegia

oral contraceptives

oral contraceptives, choreiform movements with

orthostatic hypotension

orthostatic hypotension, idiopathic

orthostatic hypotension, treatment of

Othello syndrome

palliative care

parasympathetic nervous system

Parkinson disease

Parkinson disease, akinetic form

Parkinson disease, arteriosclerotic

Parkinson disease, asymmetric onset

Parkinson disease, axial symptoms

Parkinson disease, benign tremulous

Parkinson disease, complications, late

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, diet restricted in protein

Parkinson disease, differential diagnosis of

Parkinson disease, drug holiday

Parkinson disease, drug induced

Parkinson disease, duration

Parkinson disease, dystonia with

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, fluctuations in

Parkinson disease, freezing phenomena in

Parkinson disease, heterogeneity of

Parkinson disease, intractable

Parkinson disease, juvenile

Parkinson disease, late onset

Parkinson disease, L-dopa nonresponsive

Parkinson disease, misdiagnosis

Parkinson disease, mode of onset

Parkinson disease, nonmotor problems of

Parkinson disease, on-off phenomena in

Parkinson disease, pathogenesis of

Parkinson disease, postencephalitic

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, rapid onset

Parkinson disease, rapid progression

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, transient

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinson disease, unilateral

Parkinson disease, wearing off

Parkinson disease, young onset

Parkinsonism multiple-system atrophy

Parkinsonism plus syndrome

Parkinsonism syndrome

pathologic gambling

patient information and support

penguin silhouette sign

periodic limb movements

periodic movements during sleep

persistent vegetative state

personality change

phenothiazine, dyskinesia associated with

phenylketonuria

postural abnormality

practice guidelines

pregnancy, neurologic complications in

pretectal syndrome

prevention of neurologic disorders

progressive neurologic disorder

progressive supranuclear palsy

prolactin, elevated

pseudobulbar palsy

psychiatric disorder

psychiatric problems in neurologic disorders

psychological testing

psychological testing, neurologic problems

psychomotor retardation

psychotic behavior

pure autonomic failure

putamen, lesion of

pyramidal tract dysfunction

pyridoxine deficiency

pyruvate-kinase deficiency anemia

rapid onset dystonia parkinsonism

reserpine and reserpine like drugs

reserpine treatment in movement disorder

respirations in CNS disease

respiratory dyskinesias

restless arms syndrome

restless leg syndrome

reversible neurologic disorder

rigidity, axial

Riley-Day syndrome

risk-benefit assessment

ropinirole, prolonged release

saccadic eye movements, abnormal

seizure, pyridoxine dependent

selective serotonin reuptake inhibitors

self-mutilation

sequencing difficulty

serotonin antagonist

serum alanine aminotransferase

shunt procedure, ventricular-complications of

Shy-Drager syndrome

single photon emission computed tomography

sleep pathology and physiology

small vessel disease

Smell Identification Test

speech disorder

speech disorder, childhood

spinocerebellar ataxia

spinocerebellar ataxia type 1

spinocerebellar ataxia type 2

spinocerebellar ataxia type 3/Machado Joseph disease

start hesitation

status epilepticus

stem cell transplantation

stereotaxic surgery

stereotyped behavior

stereotyped behavior, drug induced

steroid therapy, CNS treatment and complications with

stimulation, deep brain

striatum, lesion of

subcortical U fibers

substantia nigra

subthalamic nucleus

subthalamic nucleus deep brain stimulation

swallow evaluation

sweating, abnormality of

sympathetic nervous system

sympathomimetic drugs

synucleinopathy

syphilis, neurologic complications with

tandem gait, ataxic

tardive dyskinesia

tardive dyskinesia, treatment of

tetrahydrobiopterin

thalamus, focused ultrasound ablation

thrombophlebitis

tinnitus, pulsatile

tonic foot response

toxins, nervous system

treatment of neurologic disorder

tremor, intention

tremor, postural

tremor, resting

tremor, surgical treatment of

tremor, thalamic stimulation for suppression of

tremor, treatment of

tricyclic antidepressant

trigeminal neuralgia

trinucleotide repeats

tyrosine hydroxylase deficiency

ultrasonography

upgaze, paralysis of

urinary incontinence

varicella zoster virus

varicella zoster virus, encephalitis

vasospasm, cerebral

vertigo, cervical

vertigo, treatment of

vision, blurred

visual impairment

visual symptoms

visuospatial disturbance

vitamin deficiency

vitamin, multiple

walking, difficulty with

white matter disease

white matter disease, subcortical

wide based gait

Showing articles 100 to 150 of 349 << Previous Next >>

Comparison of Therapeutic Effects & Mortality Data of Levodopa & Levodopa with Selegiline in Pts with Early, Mild Parkinson's
BMJ 311:1602-1607, 15831995., Lee,A.J.,et al, 1995

The Effect of Deprenyl and Levodopa on the Progression of Parkinson's Disease
Ann Neurol 38:771-777, Olanow,C.W.,et al, 1995

Early Differential Diagnosis of Parkinson's Disease with F-flurodeoxyglucose and Positron Emission Tomography
Neurol 45:1995-2004, Eidelberg,D.,et al, 1995

Dopamine, Dystonia, and the Deficient Co-Factor
Lancet 345:1130, Williams,A.C., 1995

A Greek-American Kindred with Autosomal Dominant, Levodopa-Responsive Parkinsonism and Anticipation
Ann Neurol 38:373-378, 3551995., Markopoulou,K.,et al, 1995

Multiple System Atrophy presenting as Parkinsonism:Clinical Features and Diagnostic Criteria
JNNP 59:144-151, Albanese,A.,et al, 1995

Occurrence of Different Cancers in Patients with Parkinson's Disease
BMJ 310:1500-1501, Moller,H.,et al, 1995

Psychosis in Advanced Parkinson's Disease:Treatment with Ondansetron, a 5-HT3 Receptor Antagonist
Neurol 45:1305-1308, Zoldan,J.,et al, 1995

Increased Incidence of Levodopa Therapy Following Metoclopramide Use
JAMA 274:1780-1782, Avorn,J.,et al, 1995

Dopa-Responsive parkinsonism Phenotype of Machado-Jospeh Disease:Confirmation of 14q CAG Expansion
Ann Neurol 48:684-687, Tuite,P.J.,et al, 1995

Drug Treatment of Parkinson's Disease
BMJ 310:575-579, Quinn,N., 1995

Comparative Study of Selegiline Plus L-Dopa-Carbidopa VS L-Dopa-Carbidopa Alone in Trtm of Parkinson's Disease
Ann Neurol 37:95-98, Brannan,T.&Yahr,M.D., 1995

Some Specific Clinical Features Differentiate Multiple System Atrophy (Striatonigral Variety) from Parkinson's Disease
Arch Neurol 52:294-298, Colosimo,C.,et al, 1995

Low-Dose Clozapine in the Treatment of Levodopa-Induced Mental Disturbances in Parkinson's Disease
Neurol 45:432-434, Rabey,J.M.,et al, 1995

Levodopa Failure in Chronic Manganism
Neurol 44:1600-1602, 15831994., Lu,C-S.,et al, 1994

Dopa-Responsive Dystonia:Pathological and Biochemical Observations in a Case
Ann Neurol 35:396-402, 3811994., Rajput,A.H.,et al, 1994

A Multicenter Double-Blind Placebo-Controlled Trial of Pergolide as an Adjunct to Sinemet in Parkinson's Disease
Movement Disorders, 9:40-471994., Olanow,C.W.,et al, 1994

Parkinson's Disease
JNNP 57:672-681, Marsden,C.D., 1994

Parkinsonism Induced by Solvent Abuse
Ann NEurol 35:616-618, Uitti,R.J.,et al, 1994

Reverse Shapiro's Syndrome:Hirayama
K. , et al, Arch Neurol 51:494-49694., , 1994

Comparisons of Therapeutic Effects of Levodopa
Levodopa & Selegiline, & Bromocriptine in Pts with Early, Mild Parkinson's, Parkinson's Res Grp in U, , BMJ 372,1993., 1993

Levodopa, Melanoma, and Parkinson's Disease
Neurol 43:674-677, Weiner,W.J.,et al, 1993

Clinical Experience with Controlled-Release Carbidopa/Levodopa in Parkinson's Disease
Neurol 43:677-681, Pahwa,R.,et al, 1993

Levodopa Improves Spatial Contrast Sensitivity in Parkinson's Disease
Arch Neurol 50:721-724, Hutton,J.T.,et al, 1993

The Spectrum of Levodopa-Related Fluctuations in Parkinson's Disease
Neurol 43:1459-1464, Riley,D.E.&Lang,A.E., 1993

Blood Levodopa Levels and Unified Parkinson's Disease Rating Scale Function:With and Without Exercise
Neurol 43:1040-1042, Goetz,C.G.,et al, 1993

Evidence for a Dopaminergic Deficit in Sporadic Amyoptrophic Lateral Sclerosis on Positron Emission Scanning
Lancet 324:1016-1018, Takahashi,H.,et al, 1993

Dopaminergic Treatment of Restless Legs and Rebound Phenomenon
Neurol 43:455, Guilleminault,C.,et al, 1993

A Clinicopathologic Study of 100 Cases of Parkinson's Disease
Arch Neurol 50:140-148, Hughes,A.J.,et al, 1993

The Effect of Exercise on Levodopa Absorption
Neurol 42:2042-2045, Carter,J.H.,et al, 1992

Apomorphine Test for Dopaminergic Response in Pts with Previously Untreated Parkinson's
Arch Neurol 49:1131-1134, Gasser,T.,et al, 1992

Deprenyl Effects of Levodopa Pharmacodynamics, Mood, and Free Radical Scavenging
Neurol 42:541-544, Baronti,F.,et al, 1992

Levodopa-Nonresponsive Lewy Body Parkinsonism:Clinicopathologic Study of Two Cases
Neurol 42:1323-1327, Mark,M.H.,et al, 1992

Periodic Triphasic Waves in Levodopa-Induced Encephalopathy
Neurol 42:444-446, Neufeld,M.Y., 1992

123I-iodobenzamide-SPECT Predicts Dopaminergic Responsiveness in patients with De Dovo Parkinsonism
Neurol 42:556-561, Schwarz,J.,et al, 1992

Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 47:1085-1087, Wolters,W.Ch.,et al, 1992

Stereotactic Ventrolateralis Thalamotomy for Refractory Tremor in Post-Levodopa Era Parkinson's Dis
J Neurosurg 75:723-730, Fox,M.W.,et al, 1991

Does Ageing Aggravate Parkinsonisn Disability?
JNNP 54:780-782, Blin,J.,et al, 1991

Dopa-Responsive Dystonia:Long-Term Treatment Response and Prognosis
Neurol 41:174-181, Nygaard,T.G.,et al, 1991

Early Combination of Selegiline and Low-Dose Levodopa as Initial Symptomatic Therapy in Parkinson's Dis
Arch Neurol 48:31-34, Elizan,T.S.,et al, 1991

Young-Onset Parkinson's Disease:A Clinical Review
Neurol 41:168-173, Golbe,L.I., 1991

Early Development of Levodopa-Induced Dyskinesias and Response Fluctuations in Young-Onset Parkinson's Disease
Neurol 41:202-205, Kostic,V., 1991

Presynaptic Parkinsonism in Olivopontocerebellar Atrophy:Clinical, pathological, and Neurochemical Evidence
Ann Neurol 30:425-428, Pascual,J.,et al, 1991

Standard & Controlled-Release Levodopa/Carbidopa in Fluctuating Parkinson's Disease on a Protein Redistribution Diet
Arch Neurol 48:402-405, Karstaedt,P.J.,et al, 1991

Neuroleptic Malignant Synd in Parkinson's after Withdrawal or Alteration of Dopaminergic Therapy
Arch Int Med 151:794-796, Keyser,D.L.&Rodnitzky,R.L., 1991

Controlled-Release Delivery of L-Dopa Associated with Nonfatal Hyperthermia, Rigidity, and Autonomic Dysfunction
Neurol 41:942-943, Cunningham,M.A.,et al, 1991

Respiratory Dysfunction Due to L-Dopa Therapy for Parkinsonism:Diagnosis Using Serial Pulmonary Function Tests
Am J Med 89:109-114, Zupnick,H.M.,et al, 1990

Sustained Enteral Administration of Levodopa Increases and Interrupted Infusion Decreases Levodopa Dose Requirements
Neurol 40:995-997, Cedarbaum,J.M.,et al, 1990

Decreased Efficacy of Levodopa with Carbidopa in Parkinsonian Patients after Adrenal-to-Caudate Implants
Neurol 40:845-846, Tsui,J.K.C.,et al, 1990

Stereotaxic Thalamotomy-Experiences from the Levodopa Era
JNNP 53:427-430, Wester,K.&Hauglie-Hanssen,E., 1990

Showing articles 100 to 150 of 349 << Previous Next >>